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Verbeek et al., 1999), RAG2 (Fong et al., 2000), and Results and Discussion
myeloblastin (Lutz et al., 2001). Indeed, ectopic expres-
sion of Myb and C/EBPs in heterologous cell types in- Overview of the Crystal Structures of the c-Myb
and v-Myb Complexesduces endogenous markers of myeloid differentiation,
including mim-1 and lysozyme genes (Ness et al., 1993). Figures 1A–1C show the crystal structure of c-Myb com-
plex I. In both c-Myb and v-Myb complexes, the contigu-Two oncogenic viral forms of Myb encoded by the
AMV and E26 viruses (AMV v-Myb and E26 v-Myb) are ous DNA fragments form a pseudocontinuous double-
stranded DNA related by a 2-fold screw axis. Within thealso known (Lipsick and Wang, 1999). The N- and
C-terminal regions of both v-Myb proteins are truncated c-Myb complex, the DNA fragments are bent signifi-
cantly (Figure 1A), while DNA bending in the v-Myb com-relative to c-Myb. Like c-Myb, E26 v-Myb activates gran-
ulocyte-specific genes, including mim-1, whereas AMV plex is slight. The R1, R2, and R3 of c-Myb form three
tandemly linked globular subdomains and bind to thev-Myb does not (Ness et al., 1989; Introna et al., 1990;
Kowenz-Leutz et al., 1997). Moreover, the phenotypes DNA mainly in the major groove (Figures 1A–1C). Within
c-Myb complex I, R1 also approaches the N-terminalof myeloid cells transformed by E26 and AMV differ: the
former resemble myeloblasts, while the latter resemble portion of a C/EBP bZip region from an adjoining com-
plex, forming one hydrogen bond and two van der Waalsmonoblasts (Introna et al., 1990). These differences were
attributed to multiple point mutations found in the DBD contacts. This intermolecular interaction appears weak,
however, and is probably not functionally important,of AMV v-Myb, which affect the transcription of unique
sets of differentiation-specific genes. since it is lost in c-Myb complex II, causing the R1
domain to become unfixed. Within the v-Myb complex,The DBD of c-Myb consists of three imperfect tandem
repeats of 51 or 52 amino acid residues, referred to as R2 and R3 form two tandemly linked globular subdo-
mains that bind to the DNA as in the c-Myb complex; R1R1, R2, and R3 from the N terminus (Kanei-Ishii et al.,
1990). Our previous analyses of the structures in solution is truncated, however, and what remains is structurally
disordered.using nuclear magnetic resonance (NMR) spectroscopy
revealed that each repeat contains three helices (1, 2, Like other bZip type protein–DNA complexes, C/EBP
C-terminal fragments containing the bZip region formand 3) with the helix-turn-helix variant motif (Ogata et
al., 1992, 1995), and that R2 and R3 are involved in homodimers with a coiled-coil structure at the leucine
zipper parts and bind to the DNA major groove at thespecific DNA recognition, while R1 loosely covers the
DNA position next to the R2 binding site (Ogata et al., basic regions of the fragments in both c-Myb and v-Myb
complexes. C/EBP–DNA interactions are similar within1994, 1995). The structure of R2 also contains a partially
exposed hydrophobic patch (Ogata et al., 1995); within c-Myb and v-Myb complexes and are not discussed
here due to space limitations. It is noteworthy, however,the corresponding region of the AMV v-Myb DBD, this
hydrophobic patch contains the three point mutations that only within the c-Myb complex does the C-terminal
leucine zipper region of a C/EBP molecule bound toresponsible for the failure of v-Myb to activate the mim-1
promoter (Ness et al., 1989; Introna et al., 1990; Ogata one DNA fragment interact with a c-Myb molecule bound
to another DNA fragment. Moreover, this interaction per-et al., 1995; Kowenz-Leutz et al., 1997), suggesting that
this hydrophobic patch is important for the interaction sists in crystal systems containing C/EBP molecules
of differing lengths—i.e., c-Myb complexes I and II. Onof c-Myb and C/EBP and for their synergistic activation
of transcription. the other hand, there is no interaction between C/EBP
and AMV v-Myb within the v-Myb complex.To establish the structural basis for the synergy be-
tween c-Myb and C/EBP and its disruption by the mu-
tations found in the AMV v-Myb DBD, we determined Specific DNA Recognition by c-Myb
the crystal structures of ternary complexes containing and AMV v-Myb
the c-Myb or AMV v-Myb DBD, the C-terminal portion c-Myb and v-Myb specifically bind to the consensus
of C/EBP, including the DBD, and a DNA fragment from sequence 5-YAACNG-3 (Y and N indicate a pyrimidine
the tom-1A promoter: c-Myb38-193–C/EBP259-336–DNA, and any base, respectively) (Biedenkapp et al., 1988;
c-Myb38-193–C/EBP273-336–DNA, and AMV v-Myb66-193– Tanikawa et al., 1993; Ogata et al., 1996; Oda et al.,
C/EBP259-336–DNA are respectively named c-Myb com- 1997), though the interaction is also affected by the
plex I, c-Myb complex II (or generally c-Myb complex consensus site’s 3 flanking sequence (Nakagoshi et al.,
without discrimination of complexes I and II), and v-Myb 1990; Howe and Watson, 1991; Weston, 1992; Ording
complex. We found that the c-Myb complex shows spe- et al., 1994; Ganter et al., 1999). The mode of DNA recog-
cific intercomplex binding between c-Myb and C/EBP, nition by c-Myb R2R3 was determined previously using
which is not shown by the v-Myb complex, and which a heteronuclear multidimensional NMR (Ogata et al.,
was confirmed in solution using GST pull-down assays. 1994); the crystal structures presented here revealed
This interaction between c-Myb and C/EBP allowed us novel features about the protein-DNA interface, which
to speculate that, via DNA looping, c-Myb and C/EBP were not identified in the NMR structure due to the line
are able to interact and cooperate despite the fact that broadening effect of the signals from the protons at the
they bind to natural promoters at some distance from interface or water-mediated interactions.
one another. We then used atomic force microscopy The c-Myb–DNA and v-Myb–DNA interactions shown
(AFM) to confirm that c-Myb and C/EBP could interact schematically in Figures 2A and 2B, respectively, reveal
through looping of the mim-1 promoter and showed its that c-Myb and v-Myb recognize DNA in similar fashion.
functional relevance, in vivo, using a luciferase trans- The structural details of the specific c-Myb–DNA interac-
tions are presented in Figure 2C. Asn183, Asn179, andactivation assay.
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Figure 1. Overviews of Three Closely Packed c-Myb Complex I Molecules and Sequences of the Proteins and DNA Comprising the c-Myb
and AMV v-Myb Complexes
(A–C) Closely packed c-Myb complex I molecules viewed from the front (A), from the side (B), and from the top (C).  helical regions within
the proteins are shown as ribbons; the remaining parts are shown as tubes. c-Myb R1, R2, and R3 and C/EBP chains (A) and (B) are
respectively colored dark yellow, pink, blue, yellow, and green. The DNA molecules are shown as a stick representation.
(D) Amino acid sequences of the c-Myb DBD, AMV v-Myb DBD, and C/EBP bZip region, and the nucleotide sequence of a 26 bp double-
stranded DNA fragment used for crystallizations. The R1R2R3 domains of c-Myb and AMV v-Myb are aligned with the helical regions indicated
on the top. The amino acid numbering for AMV v-Myb was adopted to correspond to that for c-Myb. The first and fourth positions of the
heptad repeat in the C/EBP leucine zipper region are highlighted in cyan and green, respectively. In the DNA sequence, C/EBP and c-Myb
binding sites are colored blue and red, respectively.
Lys182 of c-Myb R3 form bipartite hydrogen bonds with notable. While one oxygen from the Glu132 carboxyl
group makes a hydrogen bond with the N4 nitrogen ofA18, A19, and G8 bases, respectively, while Glu132 and
Lys128 of c-Myb R2 form hydrogen bonds with C20 and C20, the other is packed against the C5 carbon of C20.
Thus, consistent with the earlier study on the methyla-G22 bases, respectively. The geometry of the recogni-
tion of C20 by the side chain of Glu132 is especially tion-controlled promoter binding of Myb (Klempnauer,
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Figure 2. DNA Recognition by c-Myb and AMV v-Myb
(A and B) Schematic representations of DNA recognition by c-Myb (A) and AMV v-Myb (B). Dashed and solid lines depict intermolecular
hydrogen bonds and van der Waals contacts, respectively. DNA bases labeled in red are involved in direct interactions with proteins.
(C) Stereo view of specific interactions between c-Myb and DNA bases. The peptide backbone of c-Myb is drawn as a pink or blue tube in
the R2 and R3 regions, respectively. Thin and bold dotted lines depict intermolecular hydrogen bonds and van der Waals interactions,
respectively. Water molecules are shown as red balls.
(D and E) Electrostatic surface potential of DNA-bound c-Myb R1R2R3 viewed from the front (D) and back (E); positively and negatively
charged areas are colored blue and red, respectively.
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1993; Tanikawa et al., 1993), methylation at the C5 car- R2, but little difference in R3 (Figure 3A). The 2 helix
bon of the cytosine in the fourth position of the Myb of v-Myb R2 is shifted to the C-terminal side along the
consensus site would be expected to disrupt the interac- helical axis, as compared with that in c-Myb. This shift
tion of the cytosine with Glu132 and weaken the binding is caused by the I91N and/or L106H mutations. Leu106
affinity of c-Myb for DNA. In addition to the hydrogen in c-Myb is partially buried in the hydrophobic core of
bonding, van der Waals contacts between the methyl- R2 and stabilizes the positions of Tyr110, Ile118, and
ene parts of the side chains of Asn183 and Ser187 and His121, while His106 in AMV v-Myb inserts into a differ-
the methyl group of T17, and between the methylene ent part of the R2 hydrophobic core to relieve a steric
part of the side chain of Lys182 and the methyl group hindrance involving Ile118, causing a conformational
of T9 are observed. The first of these is thought to change in the side chain of Ile118 and a 2.5 A˚ shift in
contribute to the pyrimidine preference in the first posi- the position of the 2 helix in R2. The side chain of
tion of the Myb consensus sequence (Oda et al., 1997). His106 in AMV v-Myb also makes a hydrogen bond with
Water-mediated Myb–DNA interactions are also ob- the Lys113 backbone, stabilizing a peptide bond linking
served within the c-Myb complex (Figures 2A and 2C). Lys113 and Arg114, which fluctuates in the DNA free
A water molecule bridging the side chains of Asn183 state of c-Myb (Ogata et al., 1995, 1996) and only be-
and Asn186 is bound to the T9 base, and the side chains comes ordered upon DNA binding (Figure 3E and Ogata
of Glu132 and Lys128 also provide water-mediated in- et al., 1994; Sasaki et al., 2000). Substitution of Ile91 in
teractions with DNA bases. Earlier studies by us showed c-Myb with an Asn also contributes to the shift of the
that Myb binding is lost if a guanine is substituted at 2 helix in AMV v-Myb R2. Within the structure of c-Myb,
the C24 position (Figure 2A) (Tanikawa et al., 1993; Ogata the side chain of Ile91, which is located at the N terminus
et al., 1996). Given the structure of the c-Myb complex, of R2, is packed toward the backbone oxygen of Lys123
the partial base limitation at this position may be ex- at the C-terminal side of the 2 helix in R2, thereby
plained by the water-mediated G4 base recognition by supporting the position of the 2 helix. By contrast,
the side chain of Lys128. Another study has shown that Asn91 in AMV v-Myb hydrogen bonds to the backbone
the sequence “YAACGN” can also serve as a Myb con- of Lys123, reducing the distance between the N terminus
sensus sequence, as can “YAACNG” (Ording et al., and the C-terminal side of the 2 helix in R2.
1996). In the case of the former, the side chain of Lys128 Unlike the I91N and L106H mutations, the V117D mu-
would be able to interact with the fifth position guanine tation also found in AMV v-Myb does not affect the
with only a minor conformational change. disposition of the secondary structural elements in R2,
but, through hydrogen bonds, stabilizes the side chain
Contribution of c-Myb R1 to the c-Myb–DNA conformation of Arg114, the backbone of which is in-
Interaction volved in DNA binding (Figure 3A).
Truncation of R1 reduces the binding affinity of c-Myb Thus, these point mutations found in AMV v-Myb R2
for DNA 5- to 6-fold (Tanikawa et al., 1993; Dini and change the packing mode of the residues in the hy-
Lipsick, 1993; Ording et al., 1994). Within the c-Myb drophobic core of R2 and make additional hydrogen
complex, R1 covers the major groove and phosphate bonds, which may affect the stability of this domain. We
backbone of the DNA at a position adjacent to the R2 found the conformation-stabilizing effect of the muta-
binding site, but makes no direct contacts with the DNA tions for the R2 domain by measuring the melting points
(Figures 1A–1C, 2D, and 2E), which is consistent with of the wild-type and the AMV v-Myb R2 domains using
our previous studies (Tanikawa et al., 1993; Ogata et the CD melting experiments: the obtained Tm values
al., 1994, 1995). Calculation of the electrostatic surface were 39.7  0.1C (Hv 	 122  1 kJ/mol) and 42.8 potential of R1R2R3 revealed that the large positively 0.1C (Hv	 160  2 kJ/mol) for the wild-type R2 andcharged surface of R1 is positioned facing the DNA
the AMV v-Myb R2, respectively. This structural stabili-
major groove and the phosphate backbone (Figures 2D
zation of R2 by AMV-type mutations may explain why
and 2E). The long-range electrostatic interaction be-
AMV v-Myb is less sensitive to SH-specific modificationstween R1 and the DNA likely increases the stability of the
than c-Myb (Brendeford et al., 1997, 1998).c-Myb–DNA complex: the labile nature of the interaction
between R1 and the DNA would allow R1 to continue
Effect of the AMV-Type Mutationsto interact with a deformed DNA region, as in Figure 1A,
on the c-Myb–DNA Interactionwhere the DNA is bent as a consequence of c-Myb
We next examined the effects of AMV-type point muta-binding C/EBP (see below). This explanation is consis-
tions of c-Myb R2 on DNA binding activity. Comparisontent with the finding of Ganter et al. (1999) that DNA
of the structures of the c-Myb and AMV v-Myb com-binding activity and the trans-activation capacity of R1-
plexes shows their DNA recognition modes to be verytruncated Myb is more easily affected by the local struc-
similar (Figures 2A and 2B). There are, however, a fewture of DNA. These authors also suggested that DNA
significant differences around the interaction site be-bending in the region interacting with R1 is important
tween the 1–2 loop of Myb R2 and the phosphatefor efficient trans-activation by Myb proteins, which sup-
backbone of the DNA, which, within the c-Myb complex,ports the functional relevance of c-Myb–C/EBP induced
includes a protein backbone–DNA minor groove interac-DNA bending observed in crystals.
tion. Within the AMV v-Myb complex, distances between
the Arg114 and Trp115 backbone nitrogens and the G4Structural Changes in c-Myb R2 Induced
phosphate oxygens are 3.4 A˚ and 4.4 A˚, respectively,by AMV-Type Mutations
while the corresponding distances in the c-Myb complexComparison of DNA-bound c-Myb R2R3 with AMV
v-Myb R2R3 reveals significant structural differences in are 2.7 A˚ and 3.2 A˚ (Figure 3B). These positional changes
Cell
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Figure 3. Structural Differences between c-Myb R2 and AMV v-Myb R2 and Close-Up Views of the Interactions among c-Myb, C/EBP,
and DNA
(A) Stereo view of the superimposed R2 domains within c-Myb (pink) and AMV v-Myb (gray) complexes. The peptide backbones are drawn
as tubes, and the side chains of residues that are mutated or exhibit different conformations in AMV v-Myb are drawn as sticks.
(B) A close-up view of the interactions between the Arg114 and Trp115 backbones and the DNA phosphate oxygens at G4 within the c-Myb
and AMV v-Myb complexes.
(C) Stereo view of the c-Myb–C/EBP interaction site. Intermolecular hydrogen bonds and K
-mediated interactions are represented by dotted
lines. Parts of c-Myb and C/EBP chains A and B are drawn as pink, yellow, and green sticks, respectively. The part of the DNA backbone
interacting with the C/EBP leucine zipper region is also shown. The metal binding sites of R1, R2, and R3 were confirmed by their high-
resolution crystal structures (T.T. et al., submitted).
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Table 1. Kinetic and Dissociation Constants of c-Myb38–193 or its Mutants Binding to DNA
c-Myb38–193 DNA KD (108M) ka (106M1s1) kd (102s1)
Wild-Type tom-1Aa 3.53  0.27 1.59  0.22 5.61  0.59
mim-1b 0.164  0.031 8.60  0.80 1.40  0.13
I91N tom-1A 2.54  0.12 3.18  0.14 8.06  0.04
mim-1 0.170  0.054 14.9  3.8 2.43  0.15
L106H tom-1A 5.29  0.01 2.56  0.45 13.6  2.5
mim-1 0.388  0.098 10.2  1.0 3.89  0.60
V117D tom-1A 1.64  0.13 4.44  0.28 7.27  1.05
mim-1 0.125  0.053 13.7  3.7 1.62  0.27
I91N/L106H tom-1A 4.46  0.06 2.85  0.50 12.7  2.4
mim-1 0.382  0.164 13.0  3.6 4.66  0.74
I91N/L106H/V117D tom-1A 183  60 0.0315  0.0074 5.51  0.55
mim-1 2.26  0.36 2.12  0.59 4.68  0.58
a5-CAATCCTTAACGGACTGAGG-3.
b5-TACATTATAACGGTTTTTTA-3.
in the Myb–DNA interface are correlated with the shift coil region of C/EBP chains A and B interact with the
1 and2 helices of c-Myb R2 to form a motif resemblingof the 2 helix of R2 described above, as well as with
a conformational change in the bound DNA. a four-helix bundle. The C/EBP family has a longer leu-
cine zipper region than other basic leucine zipper pro-Previously, EMSA studies showed that AMV-v-Myb-
type mutations in the Myb DBD destabilize the Myb– teins; the C-terminal region of the leucine zipper is ex-
tended by one heptad repeat. Within the c-Myb complex,DNA complex (Brendeford et al., 1997), and that the DNA
binding affinity of the AMV v-Myb DBD is more sensitive this extended C-terminal leucine zipper region assumes
a coiled-coil formation upon binding to c-Myb; withinto the specific Myb consensus site flanking sequence,
which affects the DNA conformation, than is c-Myb DBD the v-Myb complex, by contrast, this region is partially
unstructured and there is no interaction between(Ganter et al., 1999). The present structural data are well
supported by these earlier findings. AMV-v-Myb-type C/EBP and v-Myb. The surface area buried between
C/EBP and c-Myb–DNA is 1438 A˚2 , which is within themutations in the c-Myb DBD weaken the interaction
between the backbone of the 1–2 loop of R2 and range of values observed in other functional protein-
protein interactions (Janin, 1997).the phosphate backbone of the DNA, which would be
compensated for by DNA deformation. The C-terminal part of C/EBP chain A lies between
the 1 and 2 helices of c-Myb R2 and forms a polarTo examine the effect of AMV-v-Myb-type mutations
on the interaction between the Myb DBD and the DNA interaction network, while the C-terminal part of C/EBP
chain B extends the interaction network by covering themore precisely, we performed a series of surface plas-
mon resonance experiments. Five AMV-v-Myb-type remaining exposed area of the 2 helix and the c-Myb-
bound DNA, proceeding to the groove between c-Mybpoint mutants of c-Myb38-193 were prepared (I91N, L106H,
V117D, I91N/L106H, and I91N/L106H/V117D), after R1, and R2. Arg114, Lys109, Tyr110, His121, K
, Lys120,
and c-Myb-bound DNA, in that order, make a circularwhich their binding affinities for the mim-1 (Myb binding
site A) and tom-1A promoter DNAs were measured (Ta- polar interaction surface with C/EBP chains A and B,
as follows: the side chain of Arg114 in the 1–2 loopble 1). While each of these mutations within R2 had
some subtle effects on Myb–DNA binding, the three of c-Myb R2 makes bipartite salt bridges with the side
chain of Glu323 in C/EBP chain A, stabilizing the con-point mutations cooperatively reduced DNA binding ac-
tivity, probably due to the positional changes around formation of the 1–2 loop, which interacts with the
DNA backbone. The side chains of Lys109 and Tyr110the 1–2 loop–DNA minor groove interaction site de-
scribed above. Remarkably, compared with the case of in the 1 helix of c-Myb R2 make hydrogen bonds with
the side chain of Gln333 in C/EBP chain A, and thethe tom-1A promoter, the impairment effect on the Myb-
DNA interaction by the three point mutations seems to side chain of His121 in the 2 helix of c-Myb R2 is
hydrogen bonded to the backbone of Leu330 of C/EBPbe partially compensated by the possible DNA deforma-
tion at the flanking T tract sequence of the Myb consen- chain A. The K
 mediates interactions between the
backbone oxygens of Ala119, Leu122, and Arg125 insus site in the case of the mim-1 promoter (Myb binding
site A). the 2 helix and 23 loop regions of c-Myb R2 and the
side chain of Glu336 in C/EBP chain B. The side chain
of Lys120 forms hydrogen bonds with the backboneInteraction of C/EBP with DNA-Bound c-Myb
Figures 1A–1C, 3C, and 3D show the interaction between atoms of Phe331 and Leu334 in C/EBP chain B. Around
the c-Myb-bound DNA molecule, the side chain ofthe c-Myb DBD in one c-Myb complex and the C-ter-
minal region of C/EBP in another. Parts of the coiled- Lys332 in C/EBP chain B makes a salt bridge with the
(D) Summary of the intermolecular van der Waals interactions between c-Myb and C/EBP.
(E) Stereo view of the c-Myb–C/EBP-DNA interaction site highlighting the interactions involved in stabilization of the 1–2 loop of c-Myb
R2. The peptide backbones of DNA-bound c-Myb (pink) and C/EBP chains A (yellow) and B (green) are drawn as tubes. Free c-Myb R2
(blue) is superimposed on the DNA-bound c-Myb R2. An alternative position for the disordered portion of the 1–2 loop of the free c-Myb
R2 is colored dark blue.
Cell
64
phosphate backbone of the DNA, while the side chain of AMV-type mutations on C/EBP binding activity in
solution, we performed GST pull-down assays usingof Arg328 in the same chain interacts with the DNA
phosphate via water molecules. The positions of Lys332 c-Myb mutants with various combinations of the AMV-
type mutations. As shown in Figure 4D, the I91N and L106Hand Arg328 are conserved as basic residues among
c-Myb-interacting C/EBP family members (C/EBP, , mutations each drastically impair c-Myb–C/EBPbinding.
As C/EBP interacts with both the 1 and 2 helices of, and ), and together these two residues provide a
basic potential surface oriented toward the DNA. c-Myb R2, the positional shift of the 2 helix in R2 in-
duced by the I91N or L106H mutations would be expectedInside the polar interaction area, hydrophobic resi-
dues from c-Myb R2 and C/EBP chains A and B form to alter the C/EBP binding surface, impairing the interac-
tion between C/EBP and the mutated Myb.van der Waals contacts. Interacting within this hy-
drophobic region are Leu106, Tyr110, the methylene As mentioned above, K
 is involved in the interaction
between Glu336 in C/EBP chain B and the peptide back-part of Arg114, Val117, the methylene part of Lys120,
and His121 from c-Myb R2; Thr326, Leu327, the methyl- bone extending from the 2 helix to the 2–3 loop of
c-Myb R2. In the AMV-v-Myb complex, the nearly regularene part of Asn329, Leu330, the methylene part of
Glu333, Leu334, and Pro335 from C/EBP chain A; and triangle orientation formed by the backbone oxygens of
Ala119, Leu122, and Arg125, which mediates K
 bind-Phe331 and Leu334 from C/EBP chain B. The site of
interaction in c-Myb R2 includes two residues that are ing, is significantly distorted by the shift of the 2 helix
in R2, and the ion is absent. This may also contributemutated in AMV v-Myb, and nearly corresponds to the
hydrophobic patch that was previously predicted to be to the reduction in Myb–C/EBP binding affinity.
Val117 of c-Myb R2 makes a number of van der Waalsan interaction site for other Myb binding proteins (Ogata
et al., 1995). contacts with C/EBP (Figures 3C and 3D). Unexpect-
edly, the V117D mutation found in AMV v-Myb doesTo confirm that the c-Myb–C/EBP interactions ob-
served in the crystallized structure really exist in solu- not impair C/EBP binding activity, but rather slightly
enhances it. Based on a modeling study, it is predictedtion, we performed GST pull-down assays under DNA-
free conditions using a GST-fused wild-type or mutated that loss of van der Waals contacts between Val117
and C/EBP would be energetically compensated forc-Myb DBD and the C/EBP C-terminal region con-
taining the bZip region (Figure 4A). GST-c-Myb1-193 and by formation of a salt bridge between the substituted
Asp117 in Myb R2 and Arg328 in C/EBP chain B. InGST-c-Myb38-193 efficiently bind to C/EBP259-345, and an
R1-truncated c-Myb DBD (GST-c-Myb90-193) exhibits only addition, Asp117 may interact with Phe331 in C/EBP
chain B through -orbitals in their side chain groups.a slight reduction in affinity for C/EBP (Figure 4B). In
contrast, AMV v-Myb DBD (GST-v-Myb66-193), which con- It is notable that these structural data, as well as the
results of GST pull-down assays, correlate well with thetains the three point mutations in R2, fails to interact with
C/EBP (Figure 4B). Like C/EBP259-345, C/EBP259-336, which phenotypes of cells infected by v-myb genes containing
the various combinations of the mutations describedwas used for the present crystallographic analyses, also
retains c-Myb binding affinity (Figure 4C). By contrast, (Introna et al., 1990).
truncation of seven residues from C/EBP259-336 to form
C/EBP259-329 almost eliminates c-Myb binding activity Interaction between c-Myb and C/EBP
under this condition, due to partial deletion of the c-Myb Bound at a Distance from One Another
binding site. C/EBP-MUT259-345, which contains four mu- on the mim-1 Promoter
tations (E323A/L330A/F331A/Q333A) of residues involved Within the c-Myb complex, the protein–protein interac-
in c-Myb recognition within the crystal structure, also tion is not between c-Myb and C/EBP bound to the
exhibits reduced c-Myb binding affinity. In these cases, same DNA fragment, but between these molecules
all mutated C/EBP fragments used retain the capacity bound to different fragments. This raises the possibility
for homodimerization and binding to DNA (data not that when bound to sites on the promoter that are well
shown). Thus, consistent with the crystal structures, apart from one another, these two transcriptional regula-
c-Myb interacts with the C-terminal region of leucine tory factors are nonetheless able to directly interact by
zipper of C/EBP in solution, whereas AMV v-Myb does mediating DNA loop formation. To test whether such
not. DNA loop formation actually occurs, we carried out a
series of atomic force microscopy (AFM) experiments
using c-Myb38-193, C/EBP259-336, and a mim-1 promoterStructural Basis for Disruption of the Interaction
of c-Myb and C/EBP by AMV-Type Mutations DNA fragment. The mim-1 promoter is one of the best
characterized promoters of c-Myb target genes, and thec-Myb is known to physically interact with C/EBP, the
bZip region of which is highly homologous to that of mim-1 gene is trans-activated by c-Myb but not by AMV
v-Myb (Ness et al., 1989; Kowenz-Leutz et al., 1997).C/EBP (Verbeek et al., 1999). Although AMV v-Myb was
reported to interact with C/EBP (Mink et al., 1996), the The promoter contains three c-Myb binding sites (A, B,
and C at base positions 147, 186 and 208, respec-v-Myb protein used in the study had the back mutations
to the c-Myb-type DBD, indicating that R2 of the v-Myb tively) (Ness et al., 1989), two C/EBP binding sites (at
base positions 65 and 169) (Ness et al., 1993; Burkprotein they used contained no mutation. That the c-Myb
DBD specifically interacts with C/EBP, while the AMV et al., 1993), and several putative Ets binding sites (Du-
dek et al., 1992). Among all of these, only c-Myb bindingv-Myb DBD does not, suggests that the C/EBP binding
affinity of AMV v-Myb is weaker than that of c-Myb, site A and the two C/EBP binding sites are reportedly
important for trans-activation of the mim-1 gene (Nesswhich can be attributed to the structural change in the
C/EBP interaction surface of R2. To examine the effect et al., 1993; Burk et al., 1993). In these experiments, we
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Figure 4. Examination of c-Myb-C/EBP Interaction and DNA Loop Formation Induced by c-Myb and C/EBP Interacting from Separated
Sites on the mim-1 Promoter
(A) Schematic diagram showing GST-fused c-Myb and C/EBP fragments and their mutants used in the GST pull-down assays.
(B) GST pull-down experiment examining the interactions between various GST-fused Myb protein fragments and C/EBP259-345. Left panel:
GST-fused Myb proteins were analyzed by SDS-PAGE followed by Coomassie Blue staining. Right panel: binding of in vitro-translated 35S
methionine-labeled C/EBP259-345 to GST-fused Myb proteins was detected by autoradiography. The amounts of the bound C/EBP259-345 are
shown under each line.
(C) GST pull-down experiment examining the interactions between GST-fused c-Myb1-193 and various C/EBP protein fragments. Left four
lanes: 10% input of in vitro-translated 35S methionine-labeled C/EBP proteins. Center four lanes: binding of labeled C/EBP proteins to GST.
Right four lanes: binding of labeled C/EBP proteins to GST-fused c-Myb1-193. The amounts of the bound C/EBP mutants are shown under
each line.
(D) GST pull-down experiment examining the interactions between various GST-fused c-Myb1-193 mutants and C/EBP259-345. Left panel: GST-
fused Myb proteins were analyzed by SDS-PAGE followed by Coomassie Blue staining. Right panel: binding of in vitro-translated 35S methionine-
labeled C/EBP259-345 to the GST-fused Myb proteins was detected by autoradiography. The amounts of bound C/EBP259-345 are shown under
each line.
(E) Schematic diagram of the DNA fragment used for AFM experiments.
(F–I) Representative AFM images showing the c-Myb38-193–C/EBP259-336–mim-1 promoter DNA complex with loop formation.
(J) Representative AFM image of the v-Myb66-193–C/EBP259-336–mim-1 promoter DNA complex.
(K) Representative AFM image of the c-Myb38-193–C/EBP259-329–mim-1 promoter DNA complex.
(L) Schematic representation of proteins bound to a straight mim-1 promoter and the stereospecific complex formed by the interaction of
c-Myb and C/EBP.
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used a mim-1 promoter DNA fragment spanning a region
from nucleotide position 161 to 
108, which includes
the C/EBP binding site at position 65 and Myb bind-
ing site A at position 147. For convenient observation
of the DNA molecule, the promoter fragment was ex-
tended with DNA sequences from vector pGL3 having
no binding sites for Myb or C/EBP (Figure 4E).
Figures 4F–4I show representative AFM photomicro-
graphs of the c-Myb38-193–C/EBP259-336–mim-1 promoter
complex with loop formation. Out of 63 DNA fragments
bound to both c-Myb38-193and C/EBP259-336, 47 fragments
(75% of total) exhibit loop formation. A more extensive
AFM micrograph is presented as supplementary mate-
rial (see Supplemental Figure S1, available online at
http://www.cell.com/cgi/content/full/[108]/1/57/DC1).
By contrast, when we used v-Myb66-193 or C/EBP259-329, in
which the heterodimerization sites have been truncated
(Figure 4A), the two proteins bind to DNA, but without
a preference for DNA loop formation between the two
protein binding sites (Figures 4J and 4K). For example,
out of observed 25 v-Myb66-193–C/EBP259-336–mim-1 pro-
moter complexes, all DNA fragments had no loop, and
out of 38 c-Myb38-193–C/EBP259-329–mim-1 promoter com-
plexes, only one DNA fragment exhibited a sharp bend.
Thus, c-Myb could directly bind to C/EBP via the inter-
action observed in crystal, provided a loop is formed in
the promoter DNA.
We then investigated the functional significance of
the c-Myb-C/EBP interaction using a luciferase assay
to assess the synergistic trans-activation of the mim-1
gene (Figure 5). QT6 cells (a quail fibroblast cell line)
were transfected with a luciferase reporter containing
the 350-bp mim-1 promoter region (nucleotides 242
to 
108) (mim-1[242]luc), which contains the three Myb
binding sites and two C/EBP binding sites, together
with the Myb and/or C/EBP expression plasmids, and
the resultant luciferase activity was measured (Figure
5B). In these assays, we used a truncated form of Myb
in which both the C-terminal 183-amino acids and the
N-terminal 37-amino acids were removed (Myb38-453), be-
cause this C-terminal truncated form has a higher trans-
activating capacity than full-length Myb. By themselves,
wild-type C/EBP (C/EBP1-345) or a C-terminal trun-
cated C/EBP form lacking part of the Myb-interacting
region (C/EBP1-329) activated the mim-1 promoter only
about 4- to 5-fold; by itself, c-Myb had no effect. A com-
bination of c-Myb and wild-type C/EBP (C/EBP1-345)
increased mim-1 promoter activity about 14.5-fold, indi-
cating that the two proteins act synergistically. When
the C-truncated C/EBP (C/EBP1-329) was used together
with c-Myb, the degree of activation was reduced to
8-fold. Furthermore, when the Myb protein containing
Figure 5. trans-Activation Experimentsthe three R2 point mutations (I91N/L106H/V117D) found
(A) Definitions of the Myb proteins used for trans-activation experi-in AMV v-Myb (v-Myb38-453 or v-Myb66-453) was used, the
ments. Also see Experimental Procedures.synergistic interaction with C/EBP was lost. This is
(B) Luciferase expression driven by the mim-1(242) reporter pro-despite the fact that AMV v-Myb and C/EBP were pre-
moter. Locations of Myb (circle) and C/EBP (elongated ellipse)viously reported to synergistically activate the mim-1 binding sites on the mim-1(242) promoter carried by the pGL3-
promoter (Mink et al., 1996); however, the v-Myb protein mim242 reporter plasmid are also shown.
used in that study contained back mutations to c-Myb- (C) Luciferase expression driven by the mim-1(161) reporter pro-
type DBD, making the R2 region like that of c-Myb. moter. Locations of Myb (circle) and C/EBP (elongated ellipse)
binding sites on the mim-1(161) promoter carried by the pGL3-Because the mim-1 promoter used in the above-
mim161 reporter plasmid are also shown.described experiment contained three Myb binding sites
and two C/EBP binding sites, the possibility remained
that the observed synergistic action was the result of
c-Myb– and v-Myb–C/EBP–DNA Complex Structures
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Table 2. Summary of X-Ray Experiments
Complex Type v-Myb c-Myb II c-Mby l c-Myb l-l1 c-Myb I-I2 c-Myb I-Br
Crystal data
a (A˚) 109.9 62.7 41.7 41.5 41.6 41.5
b (A˚) 166.7 73.4 157.0 157.1 157.1 157.2
c (A˚) 39.6 161.7 55.9 55.6 55.5 55.2
 () 90.0 90.0 100.2 100.3 100.3 100.1
Space group P212l2 P212l21 P21 P21 P21 P21
Data collection
Wavelength (A˚) 1.0200 1.0400 0.97934 0.9195 0.97934 1.0200 0.9197 0.9191
Resolution (A˚) 20–2.1 20–2.45 20–2.7 20–2.9 20–2.7 20–3 20–3 20–3
Observations 162864 205777 58631 38259 57964 41537 40671 38859
Unique reflections 42104 27451 18605 14141 18263 13279 13170 13051
Completeness (%) 97.3 99.0 96.0 93.4 96.8 97.5 96.7 96.0
Rsym 0.069 0.072 0.046 0.045 0.050 0.054 0.056 0.065
I/(I) 23.9 27.5 25.3 22.5 24.1 19.8 17.6 16.0
Phasing (3.2 A˚ resolution) MIR MAD
Rcullis, isomorphous or dispersive/
anomalous 0.96 0.94 —/1.00 0.66/0.72 0.73/0.72
Phasing power, isomorphous or
dispersive/anomalous 0.41 0.45 —/0.35 1.40/1.40 1.26/1.44
Figure of merit (each method) 0.19 0.42
Figure of merit (combined) 0.45
Refinement
Resolution (A˚) 20–2.23 20–2.45 20–2.8
Reflections with F  0 35692 27319 16664
Atoms 3279 3266 3577
Rcryst 0.245 0.229 0.222
Rfree (5% of reflections) 0.288 0.267 0.277
Rms deviations
bonds (A˚) 0.005 0.005 0.006
angles () 1.07 1.12 1.14
Ramachandran plot (% of residues
in regions)
core 92.8 92.4 89.7
additionally allowed 7.3 7.1 10.3
generously allowed 0.0 0.4 0.0
the interaction of c-Myb and C/EBP bound in close interacts with the DNA phosphate backbone from both
the minor and major grooves via the backbone amideproximity to one another. To eliminate that possibility,
we used another luciferase reporter containing the groups of Arg114 and Trp115 (Figures 3B and 3E). As
we reported previously, the peptide bond linking Lys113269-bp mim-1 promoter (nucleotides 161 to 
108)
(mim-1[161]luc), which has one Myb binding site at147 and Arg114 is flexible in the DNA-free state (Ogata et
al., 1995, 1996; T.T. et al., submitted); however, whenand one C/EBP binding site at 65 (Figure 5C). Al-
though the degree of activation was somewhat lower C/EBP binds to the c-Myb–DNA complex, major struc-
tural changes occur around the C terminus of 1 andthan that seen with mim-1(242)luc, the data are quite
similar, indicating that the interaction of c-Myb and the N terminus of 2 in R2, which ultimately affects the
conformation of the 1–2 loop, thereby stabilizing thisC/EBP bound to the promoter at a distance from one
another plays a key role for the synergistic activation of part of c-Myb R2 (Figure 3E). In particular, the side chain
of Arg114 in the 1–2 loop, which interacts with thetranscription.
DNA minor groove, forms a salt bridge with the side
chain of Glu323 in C/EBP chain A. AMV v-MybDNAA Possible Mechanism for Protein Assembly
from a Distance binding escapes such regulation by C/EBP; instead,
the substituted His106 and Asp117 residues, respec-We recently showed that conformational stabilization of
a flexible “regulatory” loop, which interacts with the DNA tively, stabilize the conformations of the flexible peptide
bond between Lys113 and Arg114 and the side chainminor groove, by a partner protein is a critical coopera-
tive mechanism adopted by transcriptional regulatory of Arg114 (Figure 3A).
proteins to increase their DNA binding affinity; the DNA
complex containing AML1/Runx-1 and CBF is a good Implications of Synergistic
Transcriptional Regulationexample (Tahirov et al., 2001a). Furthermore, structural
comparisons of that complex with other multi-protein– Most genes have promoter and enhancer regions that
span hundreds of base pairs and contain multiple bind-DNA complexes suggest the proposed mechanism is a
common element of protein assembly on promoter DNA. ing sites for a variety of transcriptional regulatory fac-
tors, often widely separated from one another. To createConsistent with that notion, a similar mechanism ap-
pears to be at work in the c-Myb–C/EBP–DNA complex an appropriate surface for efficient interaction of tran-
scriptional coactivators, however, a spatially close ar-described here. The regulatory 1–2 loop of c-Myb R2
Cell
68
The structure of c-Myb complex I was solved using a combinationrangement of regulatory proteins bound to DNA seems
of the MIR and MAD methods. Two iodine positions were locatedto be required. In that regard, many Myb target genes
initially for complex I-I2 by isomorphous difference Pattersonalso contain C/EBP binding sites, which are often
search. SIR phases calculated with refined iodine positions of com-
widely separated from the Myb binding sites. The crystal plex I-I2 were then used for isomorphous difference Fourier map
structure of the c-Myb-C/EBP complex presented calculation, enabling location of the iodine position in complex I-I1.
MIR phases of iodine derivatives were used to locate the brominehere, as well as the DNA loop created by the interaction
positions in complex I-Br. The MAD and MIR phases calculated atof c-Myb and C/EBP and observed using AFM, support
3.2 A˚ resolution were combined and used for density modificationthe notion that the direct interaction of c-Myb DBD with
and phase extension from 4 A˚ to 2.8 A˚ with structural factors of theC/EBP bZip bound at a distance contributes to the
c-Myb complex I crystal. The resultant electron density map was
generation of a molecular assembly suitable for syner- slightly better than the modified MAD map, and enabled the protein
gistic activation of the target promoter. Both c-Myb and backbones to be traced and all of the DNA bases and most of the
DNA backbone to be fitted. All calculations were performed withC/EBP bind to the coactivator CBP via their transcrip-
CNS version 0.9a (Bru¨nger et al., 1998). An initial model of c-Mybtional activation domain (Dai et al., 1996; Oelgeschla¨ger
complex I was built using TURBO-FRODO software and then refinedet al., 1996). Although the folding structures of their
with CNS. The structures of c-Myb complex II and v-Myb complexactivation domains remain unknown, c-Myb-C/EBP
were solved using the molecular replacement method with the re-
complex formation may enhance binding of the CBP fined structure of c-Myb complex I as a search model, and then
molecule (Figure 4L). Indeed, most likely, multiple en- refined with CNS. The structure of the entire c-Myb R1R2R3 domain
was determined for c-Myb complex I. While in c-Myb complex II,hancer binding proteins and coactivators interact via
the electron density map was interpretable starting from the thirdvarious domains to form a large protein complex, the
helix of R1, and no electron density was observed for the N-terminalso-called “enhanceosome,” which synergistically stimu-
26 amino acids of v-Myb within the v-Myb complex. In addition, thelates transcription. Contributing to the formation of the
N-terminal seven to nine amino acids of C/EBPwere flexible within
enhanceosome is the capacity of transcription factors to the structures of c-Myb complex I and v-Myb complex, making
interact despite being bound to widely separated sites. electron density uninterpretable. The data statistics used for the final
refinement and for assessing the quality of the refined structures areIn addition to the C/EBP binding site, some promoters
summarized in Table 2. The figures containing the crystal structuresof c-Myb target genes commonly contain the binding
were prepared using TURBO-FRODO, QUANTA, and GRASP (Ni-sites for Ets, AML1/Runx-1, or GATA-1 (Hernandez-
cholls et al., 1991) softwares.Munain and Krangel, 1994; Bristos-Bray and Friedman,
1997; Zhang et al. 1997). It is therefore possible that,
CD Melting Experiments
like C/EBP, these transcription factors also may inter- Thermal denaturations of the wild-type R2 and the AMV v-Myb R2
act with c-Myb via the DBD. Moreover, c-Myb DBD also domains were measured with CD while increasing the temperature
reportedly interacts with several other factors, including at a rate of 0.75 K/min using a J-725 spectropolarimeter (Jasco,
Japan). Samples were dissolved in 50 mM potassium phosphatep100, HSF3, and D-type cyclin (Ness, 1999; Kanei-Ishii
buffer (pH 7.5) containing 50 mM KCl and 10 mM DTT. The concen-et al., 1997; Ganter et al., 1998), suggesting that the
tration of each sample was 0.02 mM. Data were collected usingc-Myb DBD may serve as a DNA/protein assembly mod-
cylindrical quartz cuvettes with a 1 mm path length, and the temper-
ule capable of mediating a wide array of interactions, ature was controlled with a thermoelectric (Peltier) temperature con-
probably in part via the C/EBP binding site in R2. trol system. Changes in ellipticity were monitored at 222 nm. The
In conclusion, the present study provides important obtained experimental data of the thermal transition were curve
fitted nonlinearly with the fixed Cp value of 1.35 kJ K1 mol1 (Moriiclues that increase our understanding of the regulation
et al., 1999).of trans-activation mediated by c-Myb and C/EBP and
the dysregulation caused by oncogenic mutations. More
GST Pull-Down Assaysbroadly, it describes the structural basis of trans-activa-
GST pull-down assays were performed using standard procedures.
tional synergy and the mechanism by which multiple To express various GST-fused Myb proteins, plasmids were con-
transcriptional regulatory factors are assembled on pro- structed using a PCR-based method with vector pGEX-4T-3 (Phar-
moter DNA for enhanceosome formation (Carey, 1998; macia). pSPUTK (STRATAGENE), a modified pSP65 vector, was
used for the in vitro transcription/translation of C/EBP and its mu-Merika and Thanos, 2001).
tant proteins. The binding buffer used contained 20 mM HEPES (pH
7.5), 300 mM NaCl, 1 mM DTT, and 0.5% NP 40.Experimental Procedures
Structure Determinations Surface Plasmon Resonance
Site-directed mutagenesis inducing point mutation of c-Myb38-193Polypeptide fragments of mouse c-Myb38-193, AMV v-Myb66-193, and
human C/EBP259-336 and C/EBP273-336 were overexpressed in Esche- was carried out using a QuikChange Site-Directed Mutagenesis kit
(STRATAGENE). The strategy for the expression and purification ofrichia coli BL21(DE3) using a T7 expression system and then puri-
fied. Sample preparation, crystallization, cryoprotection of native the mutated Myb proteins was the same as that used with the wild-
type c-Myb DBD. A BIAcore 2000 biosensor system (Pharmaciaand heavy atom derivative crystals, and X-ray diffraction data collec-
tion made on a RIKEN beamline BL45XU at SPring-8 (Harima, Japan) Biosensor, Uppsala) was used to measure the interaction between
c-Myb38-193 or its mutants and two double-stranded DNA fragmentshave been described elsewhere (Tahirov et al., 2001b; Yamamoto
et al., 1998). The compositions of the complexes were as follows. (5-CAATCCTTAACGGACTGAGG-3 and 5-TACATTATAACGGTTT
TTTA-3) derived from the tom-1A and mim-1 (Myb binding site A)c-Myb complex I: c-Myb38-193, C/EBP259-336, and DNA; c-Myb complex
I-I1: c-Myb38-193, C/EBP259-336, and DNA-I1; c-Myb complex I-I2: promoters, respectively. The biotinated DNA was bound to the bio-
sensor chip SA via streptavidin preimmobilized to dextran on thec-Myb38-193, C/EBP259-336, and DNA-I2; c-Myb complex I-Br: c-Myb38-193,
C/EBP259-336, and DNA-Br; c-Myb complex II: c-Myb38-193, C/EBP273-336, chip surface. The ligand was diluted to 0.2 M in 100 mM potassium
phosphate buffer (pH 7.4) containing 300 mM NaCl and 0.005%and DNA; v-Myb complex: v-Myb66-193, C/EBP259-336, and DNA. The
proteins used and the native DNA sequences are shown in Figure Tween 20, and applied to the sensor chip surface at a rate of 5 l/
min until 38 (for tom-1A DNA) and 25 (for mim-1DNA) resonance1D, and the bromine (DNA-Br) and iodine (DNA-I1 and DNA-I2) deriv-
atized DNA sequences are as described previously (Tahirov et al., units were obtained. The running buffer was 100 mM potassium
phosphate buffer (pH 7.4) containing 70 mM NaCl and 0.005%2001b).
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Tween 20; as analytes, c-Myb38-193 or its mutants were diluted to system (Digital Instruments Inc., Santa Barbara, CA) in the tapping
mode at room temperature in air. Silicon cantilevers of 127 mvarious concentrations in the same solution and then injected over
the immobilized ligand at a rate of 100 l/min until the injected in length with a spring constant of 48N/m were purchased from
Nanosensors (Wetzlar-Blankenfeld, Germany). Typical resonant fre-volume reached 330 l. Dissociation of the analytes was then mea-
sured by injecting the running buffer alone. All experiments were quencies of these tips were 340 kHz. The 512  512 pixel images
were collected at a rate of two scan lines per second. The contourperformed at 21C. Data were analyzed with BIA evaluation version
3.0 using a nonlinear least squares method to obtain the association lengths of the protein-DNA complex were determined using Image
Gauge (FUJIFILM, Japan).and dissociation rate constants (ka and kd, respectively). For this,
the global fitting of the association and dissociation phases of the
response curves using a 1:1 binding model was applied. The fittings Acknowledgments
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